| Zhang, Lu |
NCT05345522: A Study of Anti-IL-6R mAb Injection in Patients With iMCD |
|
|
| Recruiting | 2 | 9 | RoW | Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg, Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 6mg/kg, Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 8mg/kg | Beijing VDJBio Co., LTD. | Idiopathic Multicentric Castleman's Disease | 11/22 | 12/24 | | |
NCT05422066: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma |
|
|
| Recruiting | 2 | 50 | RoW | Selinexor, ATG-010, Xpovio, Rituximab, RiTUXimab Injection, Cyclophosphamide, Cyclophosphamide Injection, Doxorubicin, Doxorubicin Hydrochloride, Vincristine, Vincristine Injection, Prednisone, Prednisone Oral Product | Li Zhiming, Antengene Corporation | DLBCL Germinal Center B-Cell Type | 07/25 | 12/25 | | |
|
| Active, not recruiting | 1 | 64 | RoW | BGB-11417, Sonrotoclax | BeiGene | Mature B-cell Malignancies | 04/26 | 04/26 | | |
NCT03377829: A Multicenter Trial of PLA vs. Surgery for Treating PTMC |
|
|
| Recruiting | N/A | 200 | Europe, RoW | PLA, Thyroid Surgery | WeiWei Zhan | Thyroid Cancer, Treatment Related Cancer | 08/21 | 12/22 | | |
| Terminated | N/A | 1706 | RoW | SpO2 directed oxygen therapy | Wuhan Union Hospital, China, Wu Jieping Medical Foundation | Critical Illness | 05/22 | 05/22 | | |
NCT06803368: Research on Clinical Recovery and Maintenance Strategies for CHB |
|
|
| Recruiting | N/A | 285 | RoW | baseline anti-HBs titer | Beijing Municipal Administration of Hospitals | Chronic Hepatitis b, Hepatitis B Vaccine | 10/27 | 10/27 | | |
| Recruiting | N/A | 3000 | RoW | | Beijing Friendship Hospital | Drug-induced Liver Injury | 12/26 | 12/28 | | |
